Skip to content
Catalyst

methylphenidatePapers

Papers about methylphenidate

papers
1,014
42 years, by papers

Newest first

451 to 500 of 1,014

Every paper here, unless its row says otherwiseIndexed under methylphenidate in PubMed's chemical list; returned by a PubMed search for methylphenidate

  • Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

    The Cochrane database of systematic reviews2015PMID 26599576Also tests methylphenidate

  • Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.

    BMJ (Clinical research ed.)2015PMID 26608309Also tests methylphenidate

  • An Open-label, Self-control, Prospective Study on Cognitive Function, Academic Performance, and Tolerability of Osmotic-release Oral System Methylphenidate in Children with Attention-deficit Hyperactivity Disorder.

    Chinese medical journal2015PMID 26608976

  • No beneficial effects of adding parent training to methylphenidate treatment for ADHD + ODD/CD children: a 1-year prospective follow-up study.

    Journal of attention disorders2014PMID 22522574

  • Methylphenidate in children with ADHD with or without learning disability.

    Journal of attention disorders2014PMID 22628142

  • Prepulse inhibition of acoustic startle and the influence of methylphenidate in children with ADHD.

    Journal of attention disorders2014PMID 22713361

  • Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys.

    Cerebral cortex (New York, N.Y.2014PMID 23048018

  • Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.

    The pharmacogenomics journal2014PMID 23588108

  • Methylphenidate use in pregnancy and lactation: a systematic review of evidence.

    British journal of clinical pharmacology2014PMID 23593966

  • Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory.

    Psychological medicine2014PMID 23597077

  • Methylphenidate improves some but not all measures of attention, as measured by the TEA-Ch in medication-naïve children with ADHD.

    Child neuropsychology2014PMID 23639119

  • Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD.

    Child neuropsychology2014PMID 23639146

  • Methylphenidate decreases fat and carbohydrate intake in obese teenagers.

    Obesity (Silver Spring, Md.)2014PMID 23839907

  • Impact of release mechanism on the pharmacokinetic performance of PAUC metrics for three methylphenidate products with complex absorption.

    Pharmaceutical research2014PMID 23921488

  • Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination.

    The international journal of neuropsychopharmacology2014PMID 24103254

  • Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial.

    Addiction (Abingdon, England)2014PMID 24118269

  • Effect of OROS methylphenidate on encopresis in children with attention-deficit/hyperactivity disorder.

    Journal of child and adolescent psychopharmacology2014PMID 24168715

  • Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial.

    International psychogeriatrics2014PMID 24169147Also indexed under methylphenidate as a PubMed major topic

  • Treatment adherence and persistence in adult ADHD: results from a twenty-four week controlled clinical trial with extended release methylphenidate.

    European psychiatry2014PMID 24176644

  • The use of actigraphy in the monitoring of methylphenidate versus placebo in ADHD: a meta-analysis.

    Attention deficit and hyperactivity disorders2014PMID 24287735

  • Attention-deficit hyperactivity disorder (ADHD) as a pyridoxine-dependent condition: urinary diagnostic biomarkers.

    Medical hypotheses2014PMID 24321736

  • The effect of a skipped dose (placebo) of methylphenidate on the learning and retention of a motor skill in adolescents with Attention Deficit Hyperactivity Disorder.

    European neuropsychopharmacology2014PMID 24332892

  • Methylphenidate hydrochloride modified-release in adults with attention deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial.

    Advances in therapy2014PMID 24371021

  • Evaluation of dosage, safety and effects of methylphenidate on post-traumatic brain injury symptoms with a focus on mental fatigue and pain.

    Brain injury2014PMID 24377326

  • Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis.

    PloS one2014PMID 24416225Also tests methylphenidate

  • A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients.

    Cancer journal (Sudbury, Mass.)2014PMID 24445757

  • A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of osmotic-controlled release oral delivery system methylphenidate HCl in adults with attention-deficit/hyperactivity disorder in Japan.

    The world journal of biological psychiatry2014PMID 24456065

  • Influence of methylphenidate on spatial attention asymmetry in adolescents with attention deficit hyperactivity disorder (ADHD): preliminary findings.

    Neuropsychologia2014PMID 24486422

  • First-trimester exposure to methylphenidate: a population-based cohort study.

    The Journal of clinical psychiatry2014PMID 24502866

  • Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: a four-week, randomized, double-blinded, placebo-controlled study.

    European neuropsychopharmacology2014PMID 24503279

  • OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.

    European neuropsychopharmacology2014PMID 24508533

  • Mediators of methylphenidate effects on math performance in children with attention-deficit hyperactivity disorder.

    Journal of developmental and behavioral pediatrics2014PMID 24509055

  • Dissociable and common effects of methylphenidate, atomoxetine and citalopram on response inhibition neural networks.

    Neuropsychologia2014PMID 24513025

  • Methylphenidate enhances cognitive performance in adults with poor baseline capacities regardless of attention-deficit/hyperactivity disorder diagnosis.

    Journal of clinical psychopharmacology2014PMID 24525641

  • Severity but not comorbidities predicts response to methylphenidate in adults with attention-deficit/hyperactivity disorder: results from a naturalistic study.

    Journal of clinical psychopharmacology2014PMID 24577256

  • The effect of methylphenidate on very low frequency electroencephalography oscillations in adult ADHD.

    Brain and cognition2014PMID 24594658

  • Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine.

    Current medical research and opinion2014PMID 24627974

  • Combination of transcranial direct current stimulation and methylphenidate in subacute stroke.

    Neuroscience letters2014PMID 24631567

  • Minimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidate.

    Journal of child and adolescent psychopharmacology2014PMID 24666268

  • Predictors of pharmacological treatment outcomes with atomoxetine or methylphenidate in patients with attention-deficit/hyperactivity disorder from China, Egypt, Lebanon, Russian Federation, Taiwan, and United Arab Emirates.

    International journal of clinical practice2014PMID 24703228

  • Methylphenidate blocks effort-induced depletion of regulatory control in healthy volunteers.

    Psychological science2014PMID 24756766

  • Catechol-O-methyltransferase Val158-Met polymorphism and a response of hyperactive-impulsive symptoms to methylphenidate: A replication study from South Korea.

    Journal of psychopharmacology (Oxford, England)2014PMID 24763183

  • Methylphenidate-risperidone combination in child psychiatry: A retrospective analysis of 44 cases.

    Annales pharmaceutiques francaises2014PMID 24780832

  • The metabotropic glutamate receptor subtype 7 rs3792452 polymorphism is associated with the response to methylphenidate in children with attention-deficit/hyperactivity disorder.

    Journal of child and adolescent psychopharmacology2014PMID 24815731

  • Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder.

    Addiction (Abingdon, England)2014PMID 24825486

  • The effects of methylphenidate on whole brain intrinsic functional connectivity.

    Human brain mapping2014PMID 24862742

  • Acute effects of 3,4-methylenedioxymethamphetamine and methylphenidate on circulating steroid levels in healthy subjects.

    Neuroendocrinology2014PMID 24903002

  • Evaluation of concomitant methylphenidate and opioid use in patients with pain.

    Journal of analytical toxicology2014PMID 24907143

  • Stimulant-induced dopamine increases are markedly blunted in active cocaine abusers.

    Molecular psychiatry2014PMID 24912491

  • Salivary neurosteroid levels and behavioural profiles of children with attention-deficit/hyperactivity disorder during six months of methylphenidate treatment.

    Journal of child and adolescent psychopharmacology2014PMID 24956271

The next 50 papers

← Previous 50